Stein Schalkwijk

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 5

Top Topics

Hiv Infected Patients

Clinical Evaluation

Mycobacterium Tuberculosis

Top Venues

British journal of clinical pharmacology

Clinical pharmacokinetics

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Stein Schalkwijk, Li Zhou, Sarit Cohen-Rabbie, Lokesh Jain, Tomoko Freshwater, Karen So, Zhongqing He, Ioanna Gioni, Helen Tomkinson, Karthick Vishwanathan, Diansong Zhou
Population pharmacokinetics and exposure-response of selumetinib and its N-desmethyl metabolite in pediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas. Cancer chemotherapy and pharmacology 88 (2) (2021)
Song Ren, Karthick Vishwanathan, Mireille Cantarini, Paul Frewer, Indira Hara, Graeme Scarfe, Wendy Burke, Stein Schalkwijk, Yan Li, David Han, Ronald Goldwater
Clinical evaluation of the potential drug-drug interactions of savolitinib: Interaction with rifampicin, itraconazole, famotidine or midazolam. British journal of clinical pharmacology (2021)
Gael Cantet, Alienor Berges, Rhianna O'Sullivan, Sarit Cohen-Rabbie, Corina Dota, Vincent Dubois, Guillemette E Benoist, Helen Tomkinson, Dinko Rekić, Joanna Parkinson, Stein Schalkwijk
Concentration-QT modelling in early clinical oncology settings: Simulation evaluation of performance. British journal of clinical pharmacology (2021)
Stein Schalkwijk, Rob Ter Heine, Angela C Colbers, Alwin D R Huitema, Paolo Denti, Kelly E Dooley, Edmund Capparelli, Brookie M Best, Tim R Cressey, Rick Greupink, Frans G M Russel, Mark Mirochnick, David M Burger
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women. Clinical pharmacokinetics 57 (11) (2019)
Stein Schalkwijk, Aaron O Buaben, Jolien J M Freriksen, Angela P Colbers, David M Burger, Rick Greupink, Frans G M Russel
Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic Modeling. Clinical pharmacokinetics 57 (6) (2019)